Effect Of Ghaza Husne Afza With Triple Compound Cream in Melasma

Efficacy Of Ghaza Husne Afza In Comparison With Triple Compound Cream In Epidermal Melasma (Kalaf)- A Split Face Controlled Clinical Trial. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081453

Enrollment

Registered

2025-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Ghaza(Facepack)Husne Afza: Patients will be advised to apply 6gm Ghaza Husne Afza mixed with rose water on the right side of the face for 1 hour at night Control Intervention1: Triple C

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed cases of epidermal malar melasma. 2.Female patients aged between 18-50 years. 3.Fitzpatricks Skin phototype III, IV and V11. 4.Patients who will give consent and are able to do follow-up.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Patients who previously applied topical treatment like hydroquinone, azelaic acid, glycolic acid, corticosteroid, or any depigmenting agents or any cosmetic procedure 1 month before the study. 3.Patients having cutaneous infections like herpes, facial warts, and active dermatoses

Design outcomes

Primary

Measure	Time frame
1.Decrease in area of involvement of mMASI scoreTimepoint: 0th Day ,15th Day,30th Day,45th Day,60th Day	—

Secondary

Measure	Time frame
1.Improvement in DLQI score 2.Improvement in photographs of the lesions Timepoint: 0th Day ,15th Day,30th Day,45th Day,60th Day	—

Countries

India

Contacts

Public ContactDr Iram Naaz

National Institute Of Unani Medicine

iramnaaz144@gmail.com9916233452

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026